Physician
Cardiology
Dr. Thomas M. Shimshak, MD
|
|
Give Review
Doctor Thomas M. Shimshak, MD is an expert in the field of Cardiology. He researched medicine at Medical College of Wisconsin. Medical College of Wisconsin is ranked 54/62 in Research/PrimaryCare. He received 3 awards: "Heart/Stroke Recognition Program", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Thomas Shimshak is also a published doctor. He has 43 paper published. The most recent paper is: Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Thomas Shimshak accepts all Medicare patients.
Publications
- Successful treatment of post-mitral Valve annuloplasty Aspergillus flavus endocarditis.
- Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in Acute coronary syndromes.
- Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable Angina pectoris undergoing percutaneo...
- Extensive thrombus prior to elective percutaneous Coronary intervention.
- Combination enoxaparin and abciximab therapy during percutaneous Coronary intervention: "NICE guys finish first".
- Infrainguinal lesion-specific device choices: round-table discussion.
- Contemporary endovascular treatment for Disease of the superficial femoral and popliteal arteries: an integrated device-based strategy.
- Successful exclusion of a left main coronary artery Aneurysm with a PTFE-covered coronary stent.
- Durable clinical benefit following Sr90 Beta irradiation therapy for in-stent restenosis in high-volume community practice.
- Bleeding risks and vascular complications following abciximab therapy for percutaneous Coronary intervention: a new look at an old problem.
- Ticlopidine monotherapy following Coronary stent deployment: "penny wise and pound foolish".
- Coronary perforation during percutaneous Coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management.
- Dalteparin in combination with abciximab during percutaneous Coronary intervention.
- Therapeutic adjuncts for immediate transfer to the catheterization laboratory in patients with Acute coronary syndromes.
- Abciximab provides cost-effective survival advantage in high-volume interventional practice.
- IIb's are not IIb's.
- Combination enoxaparin-abciximab therapy during Coronary intervention: the next standard of care?
- Contemporary percutaneous treatment of unprotected left main Coronary stenoses: initial results from a multicenter registry analysis 1994-1996.
- Coronary angioplasty versus repeat Coronary artery bypass grafting for patients with previous bypass surgery.
- Results of direct percutaneous transluminal Coronary angioplasty in octogenarians.
- Failed direct coronary angioplasty for Acute myocardial infarction: in-hospital outcome and predictors of death.
- Initial and long-term outcome of 83 patients after balloon angioplasty of totally occluded bypass grafts.
- Directional atherectomy of left main stenoses.
- Regional distribution of blood flow at the onset of right ventricular diastolic collapse during cardiac tamponade.
- Stimulation of myocardium during reperfusion injury by a new inotrope-vasodilator agent, MCI-154.
- Comparative effects of inotropic agents on Coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
- Application of percutaneous transluminal Coronary angioplasty to the internal mammary artery graft.
- Successful percutaneous transluminal angioplasty of an obstructed abdominal aorta secondary to a chronic Dissection.
- Recovery of contractile function in post-ischaemic reperfused myocardium of conscious dogs: influence of nicorandil, a new antiAnginal agent.
- Percutaneous transluminal angioplasty in diffuse subtotally occluded vein grafts.
- Cardiovascular actions of a new dihydropyridine calcium antagonist, 8363-S: comparison with nifedipine and nicardipine in awake, unsedated dogs.
- High-dose contrast agent administration during complex Coronary angioplasty.
- Outcome following emergency Coronary artery bypass grafting for failed elective balloon Coronary angioplasty in patients with prior Coronary bypass.
- Catheterization laboratory events and hospital outcome with direct angioplasty for Acute myocardial infarction.
- Multivessel Coronary angioplasty from 1980 to 1989: procedural results and long-term outcome.
- Results of primary angioplasty for Acute myocardial infarction in patients with multivessel coronary artery disease.
- Timing and mechanism of in-hospital and late death after primary coronary angioplasty during Acute myocardial infarction.
- Early postoperative balloon Coronary angioplasty for failed Coronary artery bypass grafting.
- Results of multivessel percutaneous transluminal Coronary angioplasty in persons aged 65 years and older.
- Safety and efficacy of percutaneous transluminal Coronary angioplasty in patients with left ventricular dysfunction.
- Myocardial salvage with direct coronary angioplasty for Acute infarction.
- Comparison of procedural results and risks of coronary angioplasty in men and women for conditions other than Acute myocardial infarction.
Schools
Medical College of Wisconsin
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioversion, Elective
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Heart/Stroke Recognition Program
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Medical College of Wisconsin Affiliated Hospitals -
Medical College of Wisconsin
Drug Facts
| NPI NUMBER | 1467567941 | |
| NPPES Provider LastName | SHIMSHAK | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 338721944 | |
| NPPES Provider State | FL | |
| Specialty Description | Cardiology | |
| Total Claim Count | 2839.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467567941 |
| Last Name Of The Provider | SHIMSHAK |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
Dr. Adriana C. Gusatu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James Tierney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard W. Short, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi K. Mareedu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew A. Schmidt, MD |
|
|
Dr. Abha Malhotra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ali N. Khan, MD
This Doctor is OpenDoctor Recommended.
|